At the time of PV diagnosis, the MEFV mutation was observed at a very low level by Sanger sequencing on PBMCs, but reanalysis 4 years later when inflammatory symptoms commenced, showed that the MEFV mutation reached a MAF of 46% in PBMCs. The gene discussed is MEFV; the disease is acquired polycythemia vera.